spirogermanium has been researched along with Germinoblastoma in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ajani, JA; Bodey, GP; Legha, SS | 1 |
| Bodey, G; Dixon, C; Hagemeister, F; Legha, S | 1 |
| Biegel, JA; Fisher, B; Klein, I; Schwartz, GN | 1 |
| Biegel, JA; Boggs, SS; Schwartz, GN | 1 |
| Cavalli, F; Clavel, M; Joss, RA; Lev, LM; Renard, J; Sessa, C; ten Bokkel Huinik, W | 1 |
| Boros, L; Glick, JH; Mann, RB; Neiman, RS; Tsiatis, AA | 1 |
| Connors, JM; Eisenhauer, E; Maroun, J; Quirt, I; Skillings, J | 1 |
7 other study(ies) available for spirogermanium and Germinoblastoma
| Article | Year |
|---|---|
Phase I study of spirogermanium given daily.
Topics: Adult; Aged; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Female; Germanium; Humans; Infusions, Parenteral; Lymphoma; Male; Middle Aged; Nausea; Nervous System Diseases; Organometallic Compounds; Ovarian Neoplasms; Spiro Compounds | 1983 |
Pulmonary toxicity associated with spirogermanium.
Topics: Antineoplastic Agents; Combined Modality Therapy; Drug Evaluation; Female; Germanium; Humans; Lung Diseases; Lymphoma; Male; Middle Aged; Organometallic Compounds; Spiro Compounds | 1984 |
Spirogermanium: effects on hematopoietic stem cells and survival of normal and tumor-bearing mice.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Female; Germanium; Hematopoietic Stem Cells; Lymphoma; Mammary Neoplasms, Experimental; Mice; Mice, Inbred AKR; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasm Transplantation; Organometallic Compounds; Spiro Compounds; Spleen | 1983 |
A model to study drug effects on lymphoma and normal cell populations using the AKR/J mouse.
Topics: Animals; Carmustine; Cell Line; Disease Models, Animal; Germanium; Karyotyping; Leukemia, Experimental; Lymphoma; Mice; Mice, Inbred AKR; Neoplasm Transplantation; Organometallic Compounds; Spiro Compounds | 1982 |
A phase II study of spirogermanium in patients with advanced malignant lymphoma.
Topics: Adult; Aged; Antineoplastic Agents; Drug Evaluation; Female; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Organometallic Compounds; Spiro Compounds | 1989 |
Phase II Eastern Cooperative Oncology Group Study of spirogermanium in previously treated lymphoma.
Topics: Adult; Aged; Antineoplastic Agents; Drug Evaluation; Germanium; Humans; Lymphoma; Middle Aged; Organometallic Compounds; Seizures; Spiro Compounds | 1986 |
A phase II study of spirogermanium as second line therapy in patients with poor prognosis lymphoma. An NCI Canada Clinical Trials Group Study.
Topics: Aged; Antineoplastic Agents; Drug Evaluation; Germanium; Humans; Lymphoma; Middle Aged; Nervous System Diseases; Organometallic Compounds; Prognosis; Spiro Compounds | 1985 |